Inhibitor versus chaperone behaviour of d-fagomine, DAB and LAB sp2-iminosugar conjugates against glycosidases: A structure–activity relationship study in Gaucher fibroblasts
- 1 October 2016
- journal article
- research article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 121, 880-891
Abstract
No abstract availableKeywords
Funding Information
- JSPS KAKENHI (25293230, 26461525)
- Takeda Science Foundation
This publication has 60 references indexed in Scilit:
- New Castanospermine Glycoside Analogues Inhibit Breast Cancer Cell Proliferation and Induce Apoptosis without Affecting Normal CellsPLOS ONE, 2013
- Chemo-enzymatic synthesis and glycosidase inhibitory properties of DAB and LAB derivativesOrganic & Biomolecular Chemistry, 2013
- Neuronopathic Gaucher's disease: induced pluripotent stem cells for disease modelling and testing chaperone activity of small compoundsHuman Molecular Genetics, 2012
- Synthesis and biological evaluation of nojirimycin- and pyrrolidine-based trehalase inhibitorsBeilstein Journal of Organic Chemistry, 2012
- Synthesis and glycosidase inhibitory activity of isourea-type bicyclic sp2-iminosugars related to galactonojirimycin and allonojirimycinTetrahedron, 2012
- Pharmacological chaperone therapy for Gaucher disease: a patent reviewExpert Opinion on Therapeutic Patents, 2011
- A Fluorescent sp2‐Iminosugar With Pharmacological Chaperone Activity for Gaucher Disease: Synthesis and Intracellular Distribution StudiesChemBioChem, 2010
- Effects of pH and Iminosugar Pharmacological Chaperones on Lysosomal Glycosidase Structure and StabilityBiochemistry, 2009
- The Carbohydrate-Active EnZymes database (CAZy): an expert resource for GlycogenomicsNucleic Acids Research, 2008
- Fibroblast screening for chaperone therapy in β-galactosidosisBrain and Development, 2006